At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant

Plasma samples taken at different time points from donors who received either AstraZeneca (Vaxzevria) or Pfizer (Comirnaty) or Moderna (Spikevax) coronavirus disease-19 (COVID-19) vaccine were assessed in virus neutralization assays against Delta and Omicron variants of concern and a reference isola...

Descripción completa

Detalles Bibliográficos
Autores principales: Singanallur, Nagendrakumar B., van Vuren, Petrus Jansen, McAuley, Alexander J., Bruce, Matthew P., Kuiper, Michael J., Gwini, Stella M., Riddell, Shane, Goldie, Sarah, Drew, Trevor W., Blasdell, Kim R., Tachedjian, Mary, Mangalaganesh, Shruthi, Chahal, Simran, Caly, Leon, Druce, Julian D., Juno, Jennifer A., Kent, Stephen J., Wheatley, Adam K., Vasan, Seshadri S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152325/
https://www.ncbi.nlm.nih.gov/pubmed/35655773
http://dx.doi.org/10.3389/fimmu.2022.883612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152325/
https://www.ncbi.nlm.nih.gov/pubmed/35655773
http://dx.doi.org/10.3389/fimmu.2022.883612

Ejemplares similares